Business Context and Reporting Period
This Form 6-K is filed by Pheton Holdings Ltd (the "Company") for the month of December 2025, dated December 5, 2025. The filing updates investors on the acquisition of iTonic Corporation ("Target"), a transaction previously announced in August 2025. The Company acquired 51% of the Target's outstanding shares, with the transaction closing on November 25, 2025.
Key Financial Metrics and Transaction Terms
The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the Company or the Target. The financial details provided relate strictly to the equity consideration structure of the acquisition:
- Equity Issuance: The Company agreed to issue 4,000,000 newly issued Class A ordinary shares ("Earn-out Shares") to the Selling Shareholders.
- Warrants: The Company issued warrants to purchase up to 3,000,000 Class A ordinary shares ("Warrant Shares") at an exercise price of $3.10 per share.
- Performance Period: Milestones for share issuance and warrant exercisability are measured from January 1, 2026, through December 31, 2028.
- Expiration: Warrants must be exercised by November 25, 2030.
Material Changes and Transaction Status
On September 28, 2025, the parties entered into Amendment No. 1 to the Stock Purchase Agreement (SPA), modifying the terms of the share acquisition. The transaction officially closed on November 25, 2025. Key changes and current status include:
- Revised Earn-out Structure: The 4,000,000 Earn-out Shares are now issued only upon the satisfaction of specific quarterly or annual performance milestones. No Earn-out Shares have been issued as of the filing date.
- Early Issuance Option: Parties may mutually agree to issue "Early Shares" in advance of milestone achievement, subject to lock-up and forfeiture provisions if milestones are not met.
- Warrant Tranches: Warrants become exercisable in tranches tied to 12 quarterly and 3 annual milestones. Upon confirmation of a milestone, the corresponding tranche is exercisable for 90 days.
Outlook, Risks, and Contingencies
Management's outlook is contingent upon the Target achieving defined business performance metrics. The filing includes significant forward-looking statements regarding the anticipated issuance of shares and warrant exercisability. Key risks and contingencies identified include:
- Performance Risk: The Target may fail to achieve the performance milestones required for the issuance of Earn-out Shares or the exercisability of Warrants.
- Timing and Approval Risk: Issuance or exercisability may be delayed or require approvals that are not obtained.
- Legal and Operational Risk: Potential disputes, claims, or legal proceedings regarding the SPA or Amendment, and adverse changes in market or operational conditions.
- General Economic Risk: Impact of economic, regulatory, or geopolitical conditions on the combined operations.
Investor Verification Checklist
- Verify the specific business performance metrics defined in the SPA for the 12 quarterly and 3 annual milestones.
- Confirm the current status of the Target's operations and whether any milestones have been met for the period ending December 31, 2025 (if applicable) or the start of the 2026 performance period.
- Review the Company's most recent Annual Report on Form 20-F for the year ended December 31, 2024, for broader risk factors and financial context not included in this 6-K.
- Monitor future filings for the written confirmation of milestone achievements and the subsequent issuance of Earn-out Shares or Warrant tranches.